Literature DB >> 24335017

Impact of MiR-21 on the expression of FasL in the presence of TGF-β1.

Xiaoxue Wang1, Ying Liu, Xi Chen, Miaobo Zhang, Zhibo Xiao.   

Abstract

BACKGROUND: Micro-ribonucleic acids (miR) are small, noncoding RNA molecules 19 to 25 nucleotides in length that typically function as negative regulators of expression for many target genes involved in cell proliferation, differentiation, and apoptosis. However, the effects of miR-21 on keloid fibroblasts are currently unknown.
OBJECTIVES: The authors investigate whether miR-21, a specific miR implicated in multiple aspects of keloid fibroblasts, affects the expression of Fas ligand (FasL) in the presence of transforming growth factor (TGF)-β1.
METHODS: The relationship between TGF-β1 and miR-21 expression was investigated by TaqMan quantitative real-time polymerase chain reaction (Life Technologies, Grand Island, New York). FasL protein was determined by Western blotting, and regulation of cell proliferation/migration/apoptosis ability by TGF-β1 inhibitor or plasmid was evaluated respectively by EdU incorporation, Transwell assay, and flow cytometry analysis.
RESULTS: Fibroblasts from keloid tissue were confirmed to express high levels of TGF-β1 and miR-21 compared with normal skin fibroblasts. Expression of TGF-β1 and miR-21 was positively correlated in fibroblasts. In addition, cells transfected with TGF-β1 inhibitor or miR-21 inhibitor showed significant increases in FasL protein levels and number of apoptotic cells compared with control cells, whereas cell growth and migration significantly decreased. The opposite results could also be confirmed when TGF-β1 was upregulated in normal skin fibroblasts.
CONCLUSIONS: TGF-β1 could effectively influence cell proliferation, apoptosis, and migration via its control of miR-21. These findings also identify a novel mechanism of interaction between TGF-β1 and miR-21 in the regulation of FasL protein, which is involved in keloid formation.

Entities:  

Keywords:  FasL; TGF-β1, miR-21; apoptosis; keloid fibroblasts; migration; proliferation; research

Mesh:

Substances:

Year:  2013        PMID: 24335017     DOI: 10.1177/1090820X13511969

Source DB:  PubMed          Journal:  Aesthet Surg J        ISSN: 1090-820X            Impact factor:   4.283


  8 in total

Review 1.  From genetics to epigenetics: new insights into keloid scarring.

Authors:  Yongjing He; Zhenjun Deng; Mansour Alghamdi; Lechun Lu; Mark W Fear; Li He
Journal:  Cell Prolif       Date:  2017-01-05       Impact factor: 6.831

2.  miR-21 targets Fas ligand-mediated apoptosis in breast cancer cell line MCF-7.

Authors:  Ming-Fu Wu; Jie Yang; Tao Xiang; Yan-Yan Shi; Li-Jiang Liu
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2014-04-08

Review 3.  Biomechanical Regulatory Factors and Therapeutic Targets in Keloid Fibrosis.

Authors:  Fan Feng; Mingying Liu; Lianhong Pan; Jiaqin Wu; Chunli Wang; Li Yang; Wanqian Liu; Wei Xu; Mingxing Lei
Journal:  Front Pharmacol       Date:  2022-05-09       Impact factor: 5.988

Review 4.  MicroRNA-21 in Skin Fibrosis: Potential for Diagnosis and Treatment.

Authors:  Yan Li; Juan Zhang; Yuying Lei; Lechun Lyu; Ruiling Zuo; Ting Chen
Journal:  Mol Diagn Ther       Date:  2017-12       Impact factor: 4.074

5.  Integrated Interaction Network of MicroRNA Target Genes in Keloid Scarring.

Authors:  Lechun Lyu; Yu Zhao; Hongquan Lu; Zijie Liu; Jiazhi Guo; Di Lu; Xiang Li
Journal:  Mol Diagn Ther       Date:  2019-02       Impact factor: 4.074

Review 6.  The Keloid Disorder: Heterogeneity, Histopathology, Mechanisms and Models.

Authors:  Grace C Limandjaja; Frank B Niessen; Rik J Scheper; Susan Gibbs
Journal:  Front Cell Dev Biol       Date:  2020-05-26

7.  Long non-coding RNA CACNA1G-AS1 promotes proliferation and invasion and inhibits apoptosis by regulating expression of miR-205 in human keloid fibroblasts.

Authors:  Xu Zhao; Xiang Jie; Ya-Kun Gao; Bing Nie; Hua Jiang
Journal:  Biosci Rep       Date:  2020-06-26       Impact factor: 3.840

Review 8.  Epigenetic modification mechanisms involved in keloid: current status and prospect.

Authors:  Wenchang Lv; Yuping Ren; Kai Hou; Weijie Hu; Yi Yi; Mingchen Xiong; Min Wu; Yiping Wu; Qi Zhang
Journal:  Clin Epigenetics       Date:  2020-11-26       Impact factor: 6.551

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.